Gefitinib is a new molecular targeted antitumor drug and recently used widely in lung cancer treatment in China. But when used for an average ten-month period, patient show resistance to gefitinib and this resistance ...
supported by grants from National Basic Research Program of China(2005CB522404,2006CB910506);The Program for Changjiang Scholars and Innovative Research Team(PCSIRT)in Universities(IRT0519);The National Natural Science Foundation of China(30771232,30671184)~~